GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bruker Corp (FRA:BKD) » Definitions » Additional Paid-In Capital

Bruker (FRA:BKD) Additional Paid-In Capital : €268 Mil(As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Bruker Additional Paid-In Capital?


Bruker's quarterly additional paid-in capital increased from Sep. 2023 (€0 Mil) to Dec. 2023 (€259 Mil) and increased from Dec. 2023 (€259 Mil) to Mar. 2024 (€268 Mil).

Bruker's annual additional paid-in capital increased from Dec. 2021 (€210 Mil) to Dec. 2022 (€242 Mil) and increased from Dec. 2022 (€242 Mil) to Dec. 2023 (€259 Mil).


Bruker Additional Paid-In Capital Historical Data

The historical data trend for Bruker's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bruker Additional Paid-In Capital Chart

Bruker Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 179.73 177.80 210.45 241.95 259.42

Bruker Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 259.42 267.81

Bruker Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Bruker Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Bruker's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Bruker (FRA:BKD) Business Description

Traded in Other Exchanges
Address
40 Manning Road, Billerica, MA, USA, 01821
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives a majority of its revenue from Europe.